TrialPhotodermatology, photoimmunology & photomedicine2026
Photothermal-Activated Platelet-Rich Plasma Versus Conventional Platelet-Rich Plasma for Melasma: A Split-Face, Double-Blind Randomized Controlled Trial.
Rueangrit Siriphanit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.